• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断时伴有转移性疾病且对多种化疗方案和靶向治疗(m-TOR抑制剂)耐药的恶性PEComa

Malignant PEComa With Metastatic Disease at Diagnosis and Resistance to Several Chemotherapy Regimens and Targeted Therapy (m-TOR Inhibitor).

作者信息

Machado Isidro, Cruz Julia, Lavernia Javier, Rayon José M, Poveda Andrés, Llombart-Bosch Antonio

机构信息

1 Instituto Valenciano de Oncología, Valencia, Spain.

2 Hospital NISA Nueve de Octubre, Valencia, Spain.

出版信息

Int J Surg Pathol. 2017 Sep;25(6):543-549. doi: 10.1177/1066896917701245. Epub 2017 May 1.

DOI:10.1177/1066896917701245
PMID:28459168
Abstract

Perivascular epithelioid cell tumors (PEComas) are infrequent neoplasms with peculiar myomelanocytic differentiation. The aggressive abdominopelvic variant is rare, with only a small number of published cases. We present an additional case of this unusual variant, which showed an aggressive histologic and clinical behavior with multiple liver metastases and resistance to several therapies. We also discuss the histological and immunohistochemical profiles as well as the differential diagnosis.

摘要

血管周上皮样细胞瘤(PEComas)是一种罕见的肿瘤,具有独特的肌黑色素细胞分化。侵袭性腹盆腔型罕见,仅有少数病例报道。我们报告了这一罕见变异型的另一例病例,其具有侵袭性的组织学和临床行为,伴有多发肝转移且对多种治疗耐药。我们还讨论了其组织学和免疫组化特征以及鉴别诊断。

相似文献

1
Malignant PEComa With Metastatic Disease at Diagnosis and Resistance to Several Chemotherapy Regimens and Targeted Therapy (m-TOR Inhibitor).诊断时伴有转移性疾病且对多种化疗方案和靶向治疗(m-TOR抑制剂)耐药的恶性PEComa
Int J Surg Pathol. 2017 Sep;25(6):543-549. doi: 10.1177/1066896917701245. Epub 2017 May 1.
2
A rare metastatic mesenteric malignant PEComa with TSC2 mutation treated with palliative surgical resection and nab-sirolimus: a case report.罕见肠系膜转移性恶性 PEComa 伴 TSC2 突变,行姑息性手术切除和纳武利尤单抗联合依维莫司治疗:一例报告。
Diagn Pathol. 2023 Apr 11;18(1):45. doi: 10.1186/s13000-023-01323-x.
3
Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors: two case reports.新辅助或辅助西罗莫司治疗恶性转移性或局部晚期血管周上皮样细胞瘤:两例报告
Anticancer Drugs. 2016 Mar;27(3):254-8. doi: 10.1097/CAD.0000000000000324.
4
Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature.mTOR抑制剂治疗晚期恶性子宫血管周上皮样细胞瘤:单中心经验及文献综述
Anticancer Res. 2016 Nov;36(11):6161-6164. doi: 10.21873/anticanres.11208.
5
Update on the imaging of malignant perivascular epithelioid cell tumors (PEComas).恶性血管周上皮样细胞瘤(PEComas)影像学研究进展。
Abdom Radiol (NY). 2016 Feb;41(2):368-76. doi: 10.1007/s00261-015-0568-8.
6
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas).化疗、VEGFR 抑制剂和 mTOR 抑制剂在高级血管周上皮样细胞肿瘤(PEComa)中的作用。
Clin Cancer Res. 2019 Sep 1;25(17):5295-5300. doi: 10.1158/1078-0432.CCR-19-0288. Epub 2019 Jun 19.
7
Combination targeted therapy of VEGFR inhibitor, sorafenib, with an mTOR inhibitor, sirolimus induced a remakable response of rapid progressive Uterine PEComa.血管内皮生长因子受体(VEGFR)抑制剂索拉非尼与哺乳动物雷帕霉素靶蛋白(mTOR)抑制剂西罗莫司联合靶向治疗,使快速进展性子宫血管周上皮样细胞瘤产生了显著疗效。
Cancer Biol Ther. 2016 Jun 2;17(6):595-8. doi: 10.1080/15384047.2016.1167290. Epub 2016 Mar 30.
8
Polypoid PEComa in the rectum of a 15-year-old girl: case report and review of PEComa in the gastrointestinal tract.一名15岁女孩直肠内的息肉样PEComa:病例报告及胃肠道PEComa综述
Am J Surg Pathol. 2009 Mar;33(3):475-82. doi: 10.1097/PAS.0b013e31819003d1.
9
Malignant perivascular epithelioid cell tumor in children: description of a case and review of the literature.儿童恶性血管周上皮样细胞肿瘤:病例描述及文献复习。
J Pediatr Surg. 2012 Jun;47(6):e31-40. doi: 10.1016/j.jpedsurg.2012.02.023.
10
Gynecologic perivascular epithelioid cell tumors (PEComas): a review of recent evidence.妇科血管周上皮样细胞肿瘤(PEComas):最新证据回顾。
Arch Gynecol Obstet. 2024 Jun;309(6):2381-2386. doi: 10.1007/s00404-024-07510-5. Epub 2024 Apr 25.

引用本文的文献

1
Systemic Treatments and Molecular Biomarkers for Perivascular Epithelioid Cell Tumors: A Single-institution Retrospective Analysis.血管周上皮样细胞肿瘤的系统治疗和分子标志物:单中心回顾性分析。
Cancer Res Commun. 2023 Jul 12;3(7):1212-1223. doi: 10.1158/2767-9764.CRC-23-0139. eCollection 2023 Jul.
2
Management Strategies for Adults with Locally Advanced, Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor (PEComa): Challenges and Solutions.局部晚期、不可切除或转移性恶性血管周上皮样细胞瘤(PEComa)成人患者的管理策略:挑战与解决方案
Cancer Manag Res. 2023 Jul 7;15:615-623. doi: 10.2147/CMAR.S351284. eCollection 2023.
3
PEComa-A Rare Uterine Neoplasm: A Case Report.
PEComa——一种罕见的子宫肿瘤:病例报告
J Reprod Infertil. 2022 Jul-Sep;23(3):224-227. doi: 10.18502/jri.v23i3.10015.
4
Natural History and Treatment Strategies of Advanced PEComas: A Systematic Review.晚期血管周上皮样细胞瘤的自然史与治疗策略:一项系统评价
Cancers (Basel). 2021 Oct 18;13(20):5227. doi: 10.3390/cancers13205227.
5
VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature.用于治疗对mTOR抑制剂耐药的子宫转移性血管周上皮样细胞瘤(PEComa)的VEGFR抑制剂。病例报告及文献综述
Front Oncol. 2021 Mar 26;11:641376. doi: 10.3389/fonc.2021.641376. eCollection 2021.
6
Histopathologic characteristics and immunotypes of perivascular epithelioid cell tumors (PEComa).血管周上皮样细胞肿瘤(PEComa)的组织病理学特征及免疫类型
Int J Clin Exp Pathol. 2019 Dec 1;12(12):4380-4389. eCollection 2019.
7
Primary kidney malignant epithelioid angiomyolipoma: Two cases report and review of literature.原发性肾恶性上皮样血管平滑肌脂肪瘤:两例报告并文献复习
Medicine (Baltimore). 2018 Aug;97(32):e11805. doi: 10.1097/MD.0000000000011805.